Skip navigation

Leadership Seminar – Building Value in Advanced Therapies

12:30 – 20:30

Location:
Penningtons Manches, 125 Wood St, London EC2V 7AW
Date:
25 April 2017
 
After a promising onset followed by a series of setbacks, cell and gene therapies are now moving beyond being exciting technology to showing real potential for innovative treatments. Companies are raising money, some are getting approvals and key players seem to have regained interest in the field thanks to new technology advances. However these treatments will not be cheap and although governments are investing in early stage research, healthcare systems don’t seem to be following readily and question the relevance of supporting their high cost.

So what’s in it for the companies developing these therapies? This seminar will discuss how to build value from advanced therapies from understanding the unmet needs and optimising a challenging development pathway. It is intended for any academic or company interested in cell and gene therapy whether from an early discovery perspective or later stage development and application.

Programme:

12.30
- Registration and Networking Lunch

13.50 - Welcome from the Hosts

Unmet Needs and Development Trends

14.00
- Overview of Research Developments in Cell and Gene Therapy 

14.25 - Overview of Industry Challenges in Cell and Gene Therapy 

14.50 - Company Case Study on How to Successfully Enter Clinical Trials 

15.15 - Company Case Study on How to Successfully Enter Clinical Trials

15.40 - Coffee Break

The Development Process

16.10
- Engineering Cells into a Product 

16.35 - IP Consideration in Cell and Gene Therapy

17.00 - Clinical Trial Design 

17.25 - Regulatory Considerations 

17.50 - Closing Remarks

18.00 - Networking and Evening Delegates Arrive

Panel Discussion on Economic Value of Advanced Therapeutics 

18.30 – 19.30 - Cell and Gene Therapy is perceived as a breakthrough technology that has the potential to tackle many of the current health challenges. Acknowledging that, public bodies invest in lots of early stage research and support the structuration of the sector but how does that reflect in the access to these new therapies for patients? This panel will discuss the health economics of advanced therapies and what could be done to allow a better access to these therapies from the tax payers who contribute to fund the research.   

19.30 - Drinks 

20.30 - End

Prices:
Gold Members: £75 +VAT 
Silver Members: £175 +VAT 
Non-Members: £275 +VAT
Academics: £75 + VAT – please contact aline@onenucleus.com for your discount code.
Title: Leadership Seminar – Building Value in Advanced Therapies
Start: 2017-04-25 12:30:00Z
End: 2017-04-25 20:30:00Z